CANADIAN CLINICAL TRIALS

Health Canada is closely tracking all potential therapeutic treatments and vaccines in development. The Department is working with vaccine developers, researchers, and manufacturers to help expedite the development and availability of medical products such as vaccines, antibodies, and drugs to prevent and treat COVID-19.

• Vaccines and Treatments Overview
• List of Authorized Clinical Trials
• List of Investigational Testing

VACCINE INDUSTRY COLLABORATIONS

Vaccine industry leaders are working closely with all levels of government, the research community and public agencies to develop solutions to address our current and future Canadian vaccine supply needs. As an industry, we are committed to dedicating and sharing our scientific expertise, technical skills and manufacturing capabilities to address this unprecedented global health crisis. Learn more. 

FOREIGN threats to Canada’s biopharmaceutical and healthcare sectors

The Canadian Security Intelligence Service (CSIS) has alerted the Canadian biotechnology industry regarding the potential for security threats which have been heightened during the COVID-19 crisis. Specifically, CSIS wants companies to be alert to potential foreign threat actors targeting Canada’s life sciences sector. While no specific threat has been identified, CSIS is of the view that the sector is more attractive and more vulnerable to threats at this juncture. CSIS has provided a chart which identifies what companies can look for to identify potential threats and includes contact information for reporting purposes.

Registry

Given the national composition of BIOTECanada’s membership, there was an opportunity to connect those who need with those who have. Recognizing this, BIOTECanada has established a sort of on-line dating service designed to match companies in need with those who have something to offer.